US Bancorp’s CapForce IBD 50 ETF FFTY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-133
Closed -$3.69K 4123
2024
Q2
$3.69K Sell
133
-18
-12% -$491 ﹤0.01% 3593
2024
Q1
$4.17K Sell
151
-66
-30% -$1.73K ﹤0.01% 3574
2023
Q4
$5.29K Hold
217
﹤0.01% 3512
2023
Q3
$4.86K Sell
217
-19
-8% -$459 ﹤0.01% 3441
2023
Q2
$6.04K Hold
236
﹤0.01% 3427
2023
Q1
$5.58K Buy
236
+70
+42% +$1.61K ﹤0.01% 3485
2022
Q4
$3.62K Hold
166
﹤0.01% 3618
2022
Q3
$4K Hold
166
﹤0.01% 3657
2022
Q2
$4K Hold
166
﹤0.01% 3640
2022
Q1
$6K Hold
166
﹤0.01% 3543
2021
Q4
$8K Sell
166
-4
-2% -$191 ﹤0.01% 3499
2021
Q3
$8K Hold
170
﹤0.01% 3517
2021
Q2
$8K Hold
170
﹤0.01% 3476
2021
Q1
$7K Hold
170
﹤0.01% 3405
2020
Q4
$7K Sell
170
-6,537
-97% -$255K ﹤0.01% 3301
2020
Q3
$250K Sell
6,707
-53
-0.8% -$1.95K ﹤0.01% 1672
2020
Q2
$233K Sell
6,760
-10,764
-61% -$334K ﹤0.01% 1671
2020
Q1
$490K Buy
17,524
+841
+5% +$28K ﹤0.01% 1204
2019
Q4
$579K Buy
16,683
+1,516
+10% +$51.3K ﹤0.01% 1291
2019
Q3
$489K Buy
15,167
+1,249
+9% +$42.7K ﹤0.01% 1378
2019
Q2
$477K Buy
13,918
+5,393
+63% +$182K ﹤0.01% 1423
2019
Q1
$286K Buy
8,525
+1,665
+24% +$52.4K ﹤0.01% 1638
2018
Q4
$189K Buy
6,860
+972
+17% +$30.1K ﹤0.01% 1790
2018
Q3
$226K Buy
5,888
+495
+9% +$18.2K ﹤0.01% 1804
2018
Q2
$189K Sell
5,393
-1,270
-19% -$44.3K ﹤0.01% 1896
2018
Q1
$222K Buy
+6,663
New +$227K ﹤0.01% 1822

Other funds holding FFTY

US Bancorp's FFTY Position: Q3 2024 in Review

US Bancorp sold out of CapForce IBD 50 ETF (FFTY) in Q3 2024, closing a stake of 133 shares — an estimated $3.69K sold.

US Bancorp first reported a position in FFTY in Q1 2018 and held it in 26 quarters. The position peaked at $579K in Q4 2019. 29 funds tracked by Wall St. Rank hold FFTY as of Q3 2024.

  • US Bancorp reported no remaining CapForce IBD 50 ETF position as of Q3 2024 after selling out during the quarter.
  • US Bancorp sold 133 CapForce IBD 50 ETF shares in Q3 2024, an estimated $3.69K.
  • US Bancorp first reported a position in CapForce IBD 50 ETF in Q1 2018 and held it in 26 quarters.
  • US Bancorp's CapForce IBD 50 ETF position peaked at $579K in Q4 2019.
  • 29 funds tracked by Wall St. Rank held CapForce IBD 50 ETF as of Q3 2024.

Based on US Bancorp's 13F filing for Q3 2024, filed 28 Oct 2024.